Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5% (ROPI-LEVO)

This is a Biomedical Research, prospective, randomized, double blind, controlled monocentric, phase IV comparison of the effects of two local anesthetics intrathecally: 0.5% levobupivacaine and ropivacaine 0.5%.

Study Overview

Detailed Description

Progress in the practice of anesthesia led to a safety requirement of growing in daily practice. Spinal anesthesia commonly used technique for surgery of the lower limbs, provides a triple neurological lock (sensory, motor and autonomic) of roots of the spinal cord by intrathecal injection of a local anesthetic agent, following the rules of and strict aseptic conditions.

Levobupivacaine and ropivacaine local anesthetic agents are considered less toxic and tend to replace the use of bupivacaine, reference molecule, but the plasma transition is extremely toxic to patients. However, there is currently no study comparing the benefits of levobupivacaine and ropivacaine in isobaric form injected intrathecally for trauma surgery of the lower limbs. We propose to conduct a prospective, randomized double-blind comparison of the use of these two molecules in spinal isobaric form by evaluating the time and duration of action (sensory and motor block), hemodynamic and ventilatory changes (sympathetic block), and the occurrence of any adverse events.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Picardie
      • Amiens, Picardie, France, 80054
        • Hervé DUPONT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient admitted to the emergency for lower limb trauma,
  • age over 18 years and below 65 years
  • lower limb trauma surgery can be performed under spinal anesthesia.

Exclusion Criteria:

  • Refusal of patients to participate in the study,
  • Patient with cons-indication to spinal anesthesia:

    • Local anesthetic allergy agents (1/13000)
    • bleeding disorders, including pharmacological origin
    • infection at the puncture site,
    • refusal of spinal anesthesia by the patient,
  • Patient trust,
  • Patients whose coagulation is abnormal.
  • Patients with cognitive impairment or incapacitated adult,
  • Multiple trauma,
  • Porphyria,
  • Central preexisting neuropathy,
  • A history of spinal surgery,
  • Epilepsy uncontrolled by treatment,
  • Hypovolemia,
  • Pregnant or lactating women,
  • Participation in another ongoing clinical trial,
  • Patient on anticoagulant therapy,
  • Patient not affiliated with a social security system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ropivacaïne 0,5%,
intrathecal administration of 15mg of ropivacaine 0.5%.
spinal anesthesia.
Active Comparator: lévobupivacaïne 0,5%
intrathecal administration of 15mg of levobupivacaine 0.5%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration of anesthesia on sensitivity
Time Frame: during 6h after induction
Thermo-algesic exploration of sensitivity through the application of an ice cube
during 6h after induction

Secondary Outcome Measures

Outcome Measure
Time Frame
Duration of anesthesia on motor block
Time Frame: during 6h after induction
during 6h after induction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hervé DUPONT, Professor, CHU Amiens France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

August 23, 2012

First Submitted That Met QC Criteria

September 4, 2013

First Posted (Estimate)

September 5, 2013

Study Record Updates

Last Update Posted (Estimate)

May 16, 2016

Last Update Submitted That Met QC Criteria

May 13, 2016

Last Verified

May 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Undergoing Lower Limb Surgery

Clinical Trials on ropivacaïne

3
Subscribe